Exactech has selected Medical Metrics (MMI) to conduct an independent evaluation of medical images from its Biphasic cartilage repair implant (BiCRI) IDE clinical trial, approved by the Taiwan Food and Drug Administration.
MMI developed imaging sequences and assessment panels which are necessary to evaluate treatment outcomes including extent of lesion repair, bone-implant integration and overall device integrity.
The prospective, randomized study will be conducted in Taiwan to assess a cartilage repair treatment.
The biphasic implant is a two-phase scaffold which is designed to promote integration with subchondral bone and regeneration of hyaline-like cartilage.
During the study, MMI will provide comprehensive analysis and management of MR images.
Exactech clinical affairs director Matt Christensen said: "MMI is a valuable resource for clinical input on study design, and their commitment to customer services is impressive."